A Phase II Trial of Bryostatin 1 in the Treatment of Metastatic Colorectal Cancer von ZONDER, Jeffrey A, SHIELDS, Anthony F, ZALUPSKI, Mark, CHAPLEN, Ruth, HEILBRUN, Lance K, ARLAUSKAS, Patricia, PHILIP, Philip A

Volltext

Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians von PERNICK, Nat L, SARKAR, Fazlul H, PHILIP, Philip A, ARLAUSKAS, Patricia, SHIELDS, Anthony F, VAITKEVICIUS, Vainutis K, DUGAN, Michael C, ADSAY, N. Volkan

Volltext

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma von Philip, Philip A., Zalupski, Mark M., Vaitkevicius, V. K., Arlauskas, Patricia, Chaplen, Ruth, Heilbrun, Lance K., Adsay, Volkan, Weaver, Donald, Shields, Anthony F.

Volltext

The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma von Dergham, S T, Dugan, M C, Joshi, U S, Chen, Y C, Du, W, Smith, D W, Arlauskas, P, Crissman, J D, Vaitkevicius, V K, Sarkar, F H

Volltext

Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: A phase II study von AHMED, S, VAITKEVICIUS, V. K, ZALUPSKI, M. M, WEI DU, ARLAUSKAS, P, GORDON, C, KELLOGG, C, SHIELDS, A. F

Volltext

Gemcitabine and UFT plus oral calcium folinate: phase I study von Philip, P A, Ibrahim, D, Zalupski, M, Arlauskas, P, Shields, A

Volltext

The clinical significance of p21WAF1/CIP‐1 and p53 expression in pancreatic adenocarcinoma von Dergham, Sanaa T., Dugan, Michael C., Joshi, Urwashi S., Chen, Yong C., Du, Wei, Smith, Daryn W., Arlauskas, Patricia, Crissman, John D., Vaitkevicius, Vainutis K., Sarkar, Fazlul H.

Volltext